ArticleScientific reports2025
A comprehensive machine learning for high throughput Tuberculosis sequence analysis, functional annotation, and visualization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With human guidance, computers now use machine learning (ML) in artificial intelligence (AI) to learn from data, detect trends, and make predictions. Software can adapt and improve with new information. Imaging scans leverage pattern recognition to predict outcomes, diagnose disorders, and suggest treatments. Tuberculosis (TB) remains the most common bacterial disease affecting humans. The World Health Organisation reported that in 2022, 1.3 million people died from tuberculosis, with the death rate potentially reaching 66% if proper treatment isn't provided. We trained ML-supervised algorithms like XG Boost, Logistic Regression, Random Forest Classifier, Ad- aBoost, and Support Vector Machine to help classify TB patients from large RNA-sequence count data. Such algorithms provided prediction accuracies of 0.963, 0.739, 0.773, 0.866, and 0.866 sequentially. This article highlights feature importance techniques using the ML model, XGBoost, with the highest prediction accuracy of 0.963, identifying significant genes in TB RNA sequence count data. Using key machine learning features, we here identified 20 pathways, 24 gene ontologies, 20 hub genes, and 22 drugs. Next, we applied advanced computational techniques, including pathway analysis, GO, hub-protein and protein-protein interactions (PPI), transcriptomic and miRNA interactions, and drug-protein interactions, to help analyze 100 highly expressed genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.